Two recent, small meta-analyses have evaluated the efficacy of PPOS protocols compared to GnRH antagonist protocols specifically in women with PCOS, however included both randomised and non-randomised studies of generally low quality (49, 50). This evidence concerns the gene GNRH1 and polycystic ovary syndrome.